Environmental enrichment lessens cognitive decline in APP23 mice without affecting brain sirtuin expression

Letizia Polito, Armando Chierchia, Marta Tunesi, Ihssane Bouybayoune, Patrick Gavin Kehoe, Diego Albani, Gianluigi Forloni

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Environmental enrichment (EE) is a non-pharmacological intervention reported to counteract pathological signs in models of Alzheimer's disease (AD). We developed EE protocols in APP23 mice and evaluated how they influenced cognitive decline and brain amyloid-β (Aβ) burden. We also investigated the involvement of sirtuins (SIRTs) as a possible molecular mediator of EE, by assessing hippocampal and cortical mRNA and protein levels of the SIRT family members (SIRT1 to SIRT7). APP23 transgenic mice were moved to EE cages (TG-EEs) starting from 3 months of age. TG-EEs were compared to transgenic mice housed in standard cages (TG-SHs) and to wild-type littermates in the two housing conditions (WT-EEs and WT-SHs). At 7 months of age, all mice were tested for behavioral performance with Morris Water Maze (MWM) and visual novel Object Recognition Test (vORT). After a month, a group underwent biochemical analyses, while another group continued in the EE environment till 18 months of age, when Aβ plaque load was assessed. At 7 months, TG-SHs had impaired behavioral performance in MWM and vORT. In contrast, TG-EE mice had restored behavioral performance. At 8 months, EE did not affect AβPP expression or processing, Aβ40/42, pGlu-Aβ3-40/3-42, or Aβ oligomer level. The expression of two Aβ degrading enzymes (insulin degrading enzyme and neprilysin) was not modulated by EE. Brain sirtuin mRNA and protein levels were unchanged, while brain-derived neurotrophic factor expression increased after EE. Aβ deposition was attenuated in 18-month-old TG-EE mice, without apparent reduction of neuroinflammatory signs. We suggest that EE had a beneficial effect on cognitive performance and lessened long-term Aβ accumulation, but brain sirtuin expression was not modulated when cognitive impairment was restored.

Original languageEnglish
Pages (from-to)851-864
Number of pages14
JournalJournal of Alzheimer's Disease
Volume42
Issue number3
DOIs
Publication statusPublished - 2014

Fingerprint

Sirtuins
Brain
Transgenic Mice
Insulysin
Neprilysin
Messenger RNA
Water
Brain-Derived Neurotrophic Factor
Amyloid
Alzheimer Disease
Proteins
Cognitive Dysfunction

Keywords

  • Alzheimer's disease
  • APP23 mice
  • cognitive impairment
  • environmental enrichment
  • sirtuin

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Geriatrics and Gerontology
  • Clinical Psychology
  • Medicine(all)

Cite this

Environmental enrichment lessens cognitive decline in APP23 mice without affecting brain sirtuin expression. / Polito, Letizia; Chierchia, Armando; Tunesi, Marta; Bouybayoune, Ihssane; Kehoe, Patrick Gavin; Albani, Diego; Forloni, Gianluigi.

In: Journal of Alzheimer's Disease, Vol. 42, No. 3, 2014, p. 851-864.

Research output: Contribution to journalArticle

Polito, Letizia ; Chierchia, Armando ; Tunesi, Marta ; Bouybayoune, Ihssane ; Kehoe, Patrick Gavin ; Albani, Diego ; Forloni, Gianluigi. / Environmental enrichment lessens cognitive decline in APP23 mice without affecting brain sirtuin expression. In: Journal of Alzheimer's Disease. 2014 ; Vol. 42, No. 3. pp. 851-864.
@article{8a48f585d8ec44f38477971975c30a99,
title = "Environmental enrichment lessens cognitive decline in APP23 mice without affecting brain sirtuin expression",
abstract = "Environmental enrichment (EE) is a non-pharmacological intervention reported to counteract pathological signs in models of Alzheimer's disease (AD). We developed EE protocols in APP23 mice and evaluated how they influenced cognitive decline and brain amyloid-β (Aβ) burden. We also investigated the involvement of sirtuins (SIRTs) as a possible molecular mediator of EE, by assessing hippocampal and cortical mRNA and protein levels of the SIRT family members (SIRT1 to SIRT7). APP23 transgenic mice were moved to EE cages (TG-EEs) starting from 3 months of age. TG-EEs were compared to transgenic mice housed in standard cages (TG-SHs) and to wild-type littermates in the two housing conditions (WT-EEs and WT-SHs). At 7 months of age, all mice were tested for behavioral performance with Morris Water Maze (MWM) and visual novel Object Recognition Test (vORT). After a month, a group underwent biochemical analyses, while another group continued in the EE environment till 18 months of age, when Aβ plaque load was assessed. At 7 months, TG-SHs had impaired behavioral performance in MWM and vORT. In contrast, TG-EE mice had restored behavioral performance. At 8 months, EE did not affect AβPP expression or processing, Aβ40/42, pGlu-Aβ3-40/3-42, or Aβ oligomer level. The expression of two Aβ degrading enzymes (insulin degrading enzyme and neprilysin) was not modulated by EE. Brain sirtuin mRNA and protein levels were unchanged, while brain-derived neurotrophic factor expression increased after EE. Aβ deposition was attenuated in 18-month-old TG-EE mice, without apparent reduction of neuroinflammatory signs. We suggest that EE had a beneficial effect on cognitive performance and lessened long-term Aβ accumulation, but brain sirtuin expression was not modulated when cognitive impairment was restored.",
keywords = "Alzheimer's disease, APP23 mice, cognitive impairment, environmental enrichment, sirtuin",
author = "Letizia Polito and Armando Chierchia and Marta Tunesi and Ihssane Bouybayoune and Kehoe, {Patrick Gavin} and Diego Albani and Gianluigi Forloni",
year = "2014",
doi = "10.3233/JAD-131430",
language = "English",
volume = "42",
pages = "851--864",
journal = "Journal of Alzheimer's Disease",
issn = "1387-2877",
publisher = "IOS Press",
number = "3",

}

TY - JOUR

T1 - Environmental enrichment lessens cognitive decline in APP23 mice without affecting brain sirtuin expression

AU - Polito, Letizia

AU - Chierchia, Armando

AU - Tunesi, Marta

AU - Bouybayoune, Ihssane

AU - Kehoe, Patrick Gavin

AU - Albani, Diego

AU - Forloni, Gianluigi

PY - 2014

Y1 - 2014

N2 - Environmental enrichment (EE) is a non-pharmacological intervention reported to counteract pathological signs in models of Alzheimer's disease (AD). We developed EE protocols in APP23 mice and evaluated how they influenced cognitive decline and brain amyloid-β (Aβ) burden. We also investigated the involvement of sirtuins (SIRTs) as a possible molecular mediator of EE, by assessing hippocampal and cortical mRNA and protein levels of the SIRT family members (SIRT1 to SIRT7). APP23 transgenic mice were moved to EE cages (TG-EEs) starting from 3 months of age. TG-EEs were compared to transgenic mice housed in standard cages (TG-SHs) and to wild-type littermates in the two housing conditions (WT-EEs and WT-SHs). At 7 months of age, all mice were tested for behavioral performance with Morris Water Maze (MWM) and visual novel Object Recognition Test (vORT). After a month, a group underwent biochemical analyses, while another group continued in the EE environment till 18 months of age, when Aβ plaque load was assessed. At 7 months, TG-SHs had impaired behavioral performance in MWM and vORT. In contrast, TG-EE mice had restored behavioral performance. At 8 months, EE did not affect AβPP expression or processing, Aβ40/42, pGlu-Aβ3-40/3-42, or Aβ oligomer level. The expression of two Aβ degrading enzymes (insulin degrading enzyme and neprilysin) was not modulated by EE. Brain sirtuin mRNA and protein levels were unchanged, while brain-derived neurotrophic factor expression increased after EE. Aβ deposition was attenuated in 18-month-old TG-EE mice, without apparent reduction of neuroinflammatory signs. We suggest that EE had a beneficial effect on cognitive performance and lessened long-term Aβ accumulation, but brain sirtuin expression was not modulated when cognitive impairment was restored.

AB - Environmental enrichment (EE) is a non-pharmacological intervention reported to counteract pathological signs in models of Alzheimer's disease (AD). We developed EE protocols in APP23 mice and evaluated how they influenced cognitive decline and brain amyloid-β (Aβ) burden. We also investigated the involvement of sirtuins (SIRTs) as a possible molecular mediator of EE, by assessing hippocampal and cortical mRNA and protein levels of the SIRT family members (SIRT1 to SIRT7). APP23 transgenic mice were moved to EE cages (TG-EEs) starting from 3 months of age. TG-EEs were compared to transgenic mice housed in standard cages (TG-SHs) and to wild-type littermates in the two housing conditions (WT-EEs and WT-SHs). At 7 months of age, all mice were tested for behavioral performance with Morris Water Maze (MWM) and visual novel Object Recognition Test (vORT). After a month, a group underwent biochemical analyses, while another group continued in the EE environment till 18 months of age, when Aβ plaque load was assessed. At 7 months, TG-SHs had impaired behavioral performance in MWM and vORT. In contrast, TG-EE mice had restored behavioral performance. At 8 months, EE did not affect AβPP expression or processing, Aβ40/42, pGlu-Aβ3-40/3-42, or Aβ oligomer level. The expression of two Aβ degrading enzymes (insulin degrading enzyme and neprilysin) was not modulated by EE. Brain sirtuin mRNA and protein levels were unchanged, while brain-derived neurotrophic factor expression increased after EE. Aβ deposition was attenuated in 18-month-old TG-EE mice, without apparent reduction of neuroinflammatory signs. We suggest that EE had a beneficial effect on cognitive performance and lessened long-term Aβ accumulation, but brain sirtuin expression was not modulated when cognitive impairment was restored.

KW - Alzheimer's disease

KW - APP23 mice

KW - cognitive impairment

KW - environmental enrichment

KW - sirtuin

UR - http://www.scopus.com/inward/record.url?scp=84907152556&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907152556&partnerID=8YFLogxK

U2 - 10.3233/JAD-131430

DO - 10.3233/JAD-131430

M3 - Article

VL - 42

SP - 851

EP - 864

JO - Journal of Alzheimer's Disease

JF - Journal of Alzheimer's Disease

SN - 1387-2877

IS - 3

ER -